Compounded Tirzepatide Injections $100
US$ 25.92
eli lilly glp-1 dominance launches pill, kicking off showdown with Novo Nordisk The GLP-1 Race in 2026:
Description
As we move through 2026, the future of metformin in type 2 diabetes treatment is under fresh scrutiny
For many patients, GLP-1s are excellent toolsbut they are not the only tools
The national average, though, obscures some significant variation
The physics of pharmacokinetics simply require more time
